Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
While more studies in psychiatric populations are needed, obesity and antipsychotic-induced obesity are more alike than different, and it is likely that other GLP-1 RAs will work in this population as well
This summary provides basic information about Tirzepatide but does not include all information known about this medicine
After an 80-week double-blinded treatment period, the participants are eligible to enter a 48-week open-label extension period, in which they are to receive bepranemab treatment for 44 weeks
It offers several benefits, including lowering blood sugar levels, promoting weight loss, improving cardiovascular health, and managing kidney disease
US$ 23.27
US$ 25.95
US$ 23.33
US$ 23.08
US$ 27.39
US$ 22.06
US$ 29.96
US$ 21.20
